Literature DB >> 10608047

Survival in Acute Myocardial Infarction Induced by Coronary Ligation: Prognostic Relevance of Certain Hemostatic Factors During the Occlusion Phase.

.   

Abstract

Alterations in various hemostatic factor have been identified as risk factors for survival after acute myocardial infarction (AMI). However, these clinical data are primarily limited to observations made during the postinfarct stage. We assessed the effects of 50 minutes of left anterior descending artery occlusion on several hemostatic factors and analyzed their changes with outcome in 18 Yorkshire swine. Blood samples were obtained from the systemic circulation at base-line and at 25 and 50 minutes of occlusion. Platelet aggregability and plasma antithrombin-III protein C, protein S, fibronectin, endothelin-1, as well as the metabolites of thromboxane and prostacyclin were measured. Of the 18 swine, 7 survived the infarct and 11 animals developed fatal ventricular fibrillation. Both groups demonstrated significant decreases in platelet aggregation, and a decline in plasma protein S when compared with baseline. Thromboxane, prostacyclin, and ondothelin-1 plasma concentrations were also markedly reduced at the end of occlusion. There were significant changes in antithrombin-III, protein C, and fibronectin levels between surviving animals and those that died of ventricular fibrillation. Acute coronary artery occlusion is associated with substantial changes in the hemostatic factors in swine. Plasma levels of fibronectin, antithrombin-111, and protein C differed between survivors and nonsurvivors and thus might serve as predictors of mortality due to fatal ventricular fibrillation during AMI. The mechanisms of these changes during the acute phase of AMI are unclear. Immediately AMI prognosis may be related to hemostatic changes not only after thrombolysis or spontaneous reperfusion, but also during the occlusion phase as well.

Entities:  

Year:  1998        PMID: 10608047     DOI: 10.1023/A:1008815914024

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  37 in total

1.  Reducing mortality in patients with extensive myocardial infarction.

Authors:  J T Willerson; O H Frazier
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

2.  The response of plasma fibronectin to acute myocardial infarction in humans.

Authors:  R F Dyck; R C Orchard; D L Senger
Journal:  Clin Invest Med       Date:  1990-06       Impact factor: 0.825

Review 3.  Aspirin as an antiplatelet drug.

Authors:  C Patrono
Journal:  N Engl J Med       Date:  1994-05-05       Impact factor: 91.245

4.  Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature.

Authors:  E Ernst; K L Resch
Journal:  Ann Intern Med       Date:  1993-06-15       Impact factor: 25.391

5.  Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries.

Authors:  S K Yao; J C Ober; A Gonenne; F J Clubb; A Krishnaswami; J J Ferguson; H V Anderson; M Gorecki; L M Buja; J T Willerson
Journal:  Circ Res       Date:  1993-11       Impact factor: 17.367

6.  Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Relationship to extent of burn and development of sepsis.

Authors:  M E Lanser; T M Saba; W A Scovill
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

7.  Antithrombin III biological activity and emotional stress in patients with coronary artery disease.

Authors:  A Canevari; F Tacconi; M Zucchella; L Pacchiarini; F Soffiantino; G Grignani
Journal:  Haematologica       Date:  1992 Mar-Apr       Impact factor: 9.941

8.  In vivo platelet activation following myocardial infarction and acute coronary ischaemia.

Authors:  A Hughes; S Daunt; G Vass; J Wickes
Journal:  Thromb Haemost       Date:  1982-10-29       Impact factor: 5.249

9.  Plasma beta-thromboglobulin as a measure of platelet activity. Effect of risk factors and findings in ischemic heart disease and after acute myocardial infarction.

Authors:  C W Pumphrey; J Dawes
Journal:  Am J Cardiol       Date:  1982-12       Impact factor: 2.778

10.  [Prognostic value of plasma levels of fibronectin in septic shock].

Authors:  J L Hortells; J A Ibáñez Estella; S Pérez de Viñaspre; A Sánchez Ibáñez; I González Barrio
Journal:  Enferm Infecc Microbiol Clin       Date:  1992-11       Impact factor: 1.731

View more
  1 in total

1.  Hypomagnesaemia as a mortality risk factor in protein-energy malnutrition.

Authors:  Cahit Karakelleoglu; Zerrin Orbak; Ferai Ozturk; Celalettin Kosan
Journal:  J Health Popul Nutr       Date:  2011-04       Impact factor: 2.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.